ALLMedicine™ Hypoglycemia Center

Sep 26th, 2021 - We describe the case of a patient with a clinical and molecular diagnosis of Beckwith-Wiedemann Syndrome (BWS) and a clinical, radiologic and histologic diagnosis of colon isolated hypoganglionosis. BWS is a genetic multisystem disorder characteri...

Sep 25th, 2021 - School-aged children with type 1 diabetes (T1D) and their parents are at risk for sleep disturbances, yet few studies have used objective measures to assess sleep characteristics in young children with T1D. Forty children (ages 5-9) with T1D and t...

Sep 23rd, 2021 - The union of dipeptidyl peptidase-4 (DPP-4) inhibitors and insulin in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) provides satisfactory glucose management without increasing adverse events (AEs). This research appraised th...

Sep 23rd, 2021 - Multiple daily injection therapy for early glycemic control in patients with type 2 diabetes mellitus is associated with hypoglycemia and weight gain. This study aimed to compare the efficacy (time in range of glucose level 70-180 mg/dL), safety (...

Sep 23rd, 2021 - The risks of intensive blood glucose lowering may outweigh the benefits in vulnerable older people. Our primary aim was to determine whether age, frailty, or dementia predict discharge treatment types for patients with type 2 diabetes (T2D) and re...

Aug 11th, 2021 - Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are us...

Aug 19th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

Oct 7th, 2019 - This joint document of the Italian Diabetes Society and the Italian Society of Nephrology reviews the natural history of diabetic kidney disease (DKD) in the light of the recent epidemiological literature and provides updated recommendations on an...

May 6th, 2019 - Identification and Management of Neonatal Hypoglycemia in the Full-Term Infant. British Association of Perinatal Medicine Framework for Practice, 2017.|2019|Hawdon JM,|prevention & control,prevention & control,standards,

Jun 1st, 2018 - Inspired by the Choosing Wisely initiative, a group of pediatric anesthesiologists representing the German Working Group on Paediatric Anaesthesia (WAKKA) coined and agreed upon 10 concise positive ("dos") or negative ("don'ts") evidence-based rec...

Jul 6th, 2021 - Patients with type 1 diabetes who used insulin degludec as their basal insulin had fewer than half the number of nocturnal hypoglycemia events, compared with patients who used insulin glargine U100, in a head-to-head crossover study with 51 patien...

Jun 28th, 2021 - A next-generation implanted continuous glucose monitor (Eversense, Senseonics/Ascensia) is accurate and safe for up to 6 months of use, new data suggest. The first-generation 90-day Eversense was approved by the US Food and Drug Administration in ...

Jun 24th, 2021 - Incretin-based agents were introduced into the diabetes treatment landscape to address postprandial glucose control. In the postprandial phase, nutrients are ingested; in response, incretins, such as glucagon-like peptide 1 (GLP-1) and gastric inh...

Jun 24th, 2021 - Incretin-based agents were introduced into the diabetes treatment landscape to address postprandial glucose control. In the postprandial phase, nutrients are ingested; in response, incretins, such as glucagon-like peptide 1 (GLP-1) and gastric inh...

Jun 14th, 2021 - NEW YORK (Reuters Health) - Patients with type 1 diabetes may be at greater risk of cognitive decline as they age, especially if they have high blood sugar, bouts of severe hypoglycemia and/or high blood pressure, researchers say. For individuals ...